- Home
- DNLI vs CMBT Comparison
DNLI vs CMBT Comparison
Compare DNLI & CMBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- CMBT
- Stock Information
- Founded
- DNLI 2013
- CMBT 1989
- Country
- DNLI United States
- CMBT Belgium
- Employees
- DNLI N/A
- CMBT N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- CMBT
- Sector
- DNLI Health Care
- CMBT
- Exchange
- DNLI Nasdaq
- CMBT NYSE
- Market Cap
- DNLI 1.8B
- CMBT 1.6B
- IPO Year
- DNLI 2017
- CMBT N/A
- Fundamental
- Price
- DNLI $12.74
- CMBT $9.07
- Analyst Decision
- DNLI Strong Buy
- CMBT
- Analyst Count
- DNLI 16
- CMBT 0
- Target Price
- DNLI $37.57
- CMBT N/A
- AVG Volume (30 Days)
- DNLI 1.7M
- CMBT 74.5K
- Earning Date
- DNLI 05-06-2025
- CMBT 05-07-2025
- Dividend Yield
- DNLI N/A
- CMBT 62.79%
- EPS Growth
- DNLI N/A
- CMBT 4.48
- EPS
- DNLI N/A
- CMBT 4.44
- Revenue
- DNLI N/A
- CMBT $940,246,000.00
- Revenue This Year
- DNLI N/A
- CMBT $6.89
- Revenue Next Year
- DNLI $372.05
- CMBT $22.59
- P/E Ratio
- DNLI N/A
- CMBT $2.03
- Revenue Growth
- DNLI N/A
- CMBT N/A
- 52 Week Low
- DNLI $10.57
- CMBT $7.65
- 52 Week High
- DNLI $33.33
- CMBT $21.26
- Technical
- Relative Strength Index (RSI)
- DNLI 42.15
- CMBT 51.48
- Support Level
- DNLI $12.37
- CMBT $8.67
- Resistance Level
- DNLI $13.63
- CMBT $9.22
- Average True Range (ATR)
- DNLI 1.24
- CMBT 0.47
- MACD
- DNLI 0.23
- CMBT 0.07
- Stochastic Oscillator
- DNLI 50.94
- CMBT 88.81
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About CMBT EURONAV
CMB.Tech NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. It generate a large parts of their revenue from voyage charters, including vessels in pools that predominantly perform voyage charters. The company organises itself into two segments: tankers and floating storage and offloading activities, or FSO. The tankers segment, which generates the majority of revenue, operates crude oil tankers on international markets. The FSO segment conducts floating production, floating storage, and offloading operations for crude oil and petroleum products.